In conclusion, ELF3, AURKA, and ADH7 were highly accurate in predicting the prognosis and clinicopathological features of patients with HNSCC, providing a new perspective for prognosis analysis and immune target therapy for HNSCC. This evidence concerns the gene AURKA and head and neck squamous cell carcinoma.